1. Shealy SC, Brigmon MM, Justo JA, Bookstaver PB, Kohn J, Al-Hasan MN (2020) Impact of reappraisal of fluoroquinolone minimum inhibitory concentration susceptibility breakpoints in gram-negative bloodstream isolates. Antibiotics 9(4):189
2. Lee CC, Lee MG, Chen YS, Lee SH, Chen YS, Chen SC et al (2015) Risk of Aortic dissection and aortic aneurysm in participants taking oral fluoroquinolone. JAMA Int Med 175(11):1839–1847
3. FDA Drug Safety Communication: FDA updates warnings for oral and injectable fluoroquinolone antibiotics due to disabling side effects. U.S. Food and Drug Administration website. https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-fda-updates-warnings-oral-and-injectable-fluoroquinolone-antibiotics. Updated 03/08/2018. Accessed 17 Aug 2021
4. U.S. Food & Drug Administration. FDA reinforces safety information about serious low blood sugar levels and mental health side effects with fluoroquinolone antibiotics; requires label changes. https://www.fda.gov/drugs/drug-safety-and-availability/fda-reinforces-safety-information-about-serious-low-blood-sugar-levels-and-mental-health-side. Published July 10, 2018. Accessed 17 Aug 2021
5. U.S. Food & Drug Administration. FDA warns about increased risk of ruptures or tears in the aorta blood vessel with fluoroquinolone antibiotics in certain patients. U.S. Food and Drug Administration website. https://www.fda.gov/drugs/drug-safety-and-availability/fda-warns-about-increased-risk-ruptures-or-tears-aorta-blood-vessel-fluoroquinolone-antibiotics. Updated 12/21/2018. Accessed 28 Jan 2022